Standard Chem & Pharm CO., LTD. (1720.TW)
TWD 61.0
(-2.09%)
TWD 61.0
(-2.09%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.33 Billion | 1.22 Billion | 827.03 Million | 922.58 Million | 637.93 Million | 484.93 Million |
| Net Income | 834.88 Million | 1.39 Billion | 1.01 Billion | 772.92 Million | 585.81 Million | 517.46 Million |
| Depreciation & Amortization | 347.77 Million | 298.6 Million | 221.06 Million | 233.78 Million | 214.12 Million | 197.93 Million |
| Deferred income taxes | - | - | - | - | -149.94 Million | - |
| Stock-based compensation | - | - | - | - | 8.64 Million | - |
| Change in working capital | -196.58 Million | -270.68 Million | -219.25 Million | 2.77 Million | -12.17 Million | -39.71 Million |
| Other non-cash items | 350.45 Million | -200.01 Million | -188.52 Million | -86.91 Million | -8.52 Million | -190.75 Million |
| Investing Cash Flow | -485.5 Million | -1.08 Billion | 819.12 Million | -710.16 Million | -280.2 Million | -139.52 Million |
| Investments in PPE | -625.69 Million | -1.19 Billion | -217.91 Million | -352.48 Million | -179.1 Million | -169.35 Million |
| Acquisitions | -166.46 Million | -15.16 Million | 739.65 Million | -69.73 Million | -29.94 Million | -490 Thousand |
| Investment purchases | -18.98 Million | -60.63 Million | -121.2 Million | -243.84 Million | -56.24 Million | -8.1 Million |
| Sales/Maturities of investments | 178.97 Million | 149.72 Million | 200.54 Million | 53 Thousand | -1.4 Million | 13.44 Million |
| Other Investing Activities | 140.19 Million | 42.78 Million | 218.04 Million | -44.15 Million | -13.5 Million | 24.98 Million |
| Financing Cash Flow | -1.07 Billion | -465.44 Million | -117.54 Million | -643.97 Million | -138.05 Million | -284.81 Million |
| Debt repayment | -76.52 Million | -2.81 Billion | -165.99 Million | -750 Million | -567.31 Million | -205.98 Million |
| Dividends payments | -446.74 Million | -446.74 Million | -321.65 Million | -268.04 Million | -268.04 Million | -285.91 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -705.91 Million | 2.79 Billion | 370.1 Million | 374.06 Million | 697.29 Million | 207.08 Million |
| Accounts receivables | 18.82 Million | -44.42 Million | -268.78 Million | -50.43 Million | 26.01 Million | -3.35 Million |
| Accounts payables | 40.63 Million | -93.89 Million | 105.31 Million | 45.77 Million | 49.98 Million | -6.44 Million |
| Inventory | -261.58 Million | -187.62 Million | -41.14 Million | 3.24 Million | -126.63 Million | -6.95 Million |
| Other working capital | 46.17 Million | 55.26 Million | -14.63 Million | 4.19 Million | 38.46 Million | -32.75 Million |
| Cash at beginning of period | 2.25 Billion | 2.56 Billion | 1.03 Billion | 1.47 Billion | 1.25 Billion | 1.19 Billion |
| Cash at end of period | 2.03 Billion | 2.25 Billion | 2.56 Billion | 1.03 Billion | 1.47 Billion | 1.25 Billion |
| Capital Expenditure | -625.69 Million | -1.19 Billion | -217.91 Million | -352.48 Million | -179.1 Million | -169.35 Million |
| Effect of forex changes on cash | 2.47 Million | 13.42 Million | -404 Thousand | -4.15 Million | -1.83 Million | 953 Thousand |
| Net cash flow / Change in cash | -222.63 Million | -305.01 Million | 1.52 Billion | -435.71 Million | 217.84 Million | 61.54 Million |
| Free Cash Flow | 710.82 Million | 30.29 Million | 609.11 Million | 570.09 Million | 458.83 Million | 315.57 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 215.76 Million | 428.28 Million | 834.88 Million | 161.71 Million | 404.95 Million | 411.7 Million |
| Depreciation & Amortization | 100.73 Million | 95.17 Million | 347.77 Million | 93.48 Million | 92.7 Million | 82.91 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -141.59 Million | -270.78 Million | -107.7 Million | 96.54 Million | -108.75 Million | 35.96 Million |
| Other non-cash items | 344.37 Million | -14.28 Million | 1.15 Billion | 234.85 Million | -24.13 Million | -230.99 Million |
| Investing Cash Flow | -131.87 Million | -237.38 Million | -653.12 Million | -127.66 Million | -176.53 Million | -94.96 Million |
| Investments in PPE | -92.56 Million | -185.94 Million | -633.83 Million | -140.56 Million | -164.47 Million | -128.57 Million |
| Acquisitions | 771 Thousand | -11.85 Million | -166.46 Million | - | -492 Thousand | - |
| Investment purchases | -48.48 Million | -72.32 Million | -18.98 Million | -9.03 Million | -9.94 Million | - |
| Sales/Maturities of investments | - | 12.5 Million | 178.97 Million | 21.3 Million | 10.69 Million | 39.39 Million |
| Other Investing Activities | 8.4 Million | 5.48 Million | -12.81 Million | 632 Thousand | -12.3 Million | -5.78 Million |
| Financing Cash Flow | -323.6 Million | -155.84 Million | -957.36 Million | -218.33 Million | -516.87 Million | -211.98 Million |
| Debt repayment | -317.13 Million | -150.28 Million | -499.03 Million | -212.26 Million | -553.38 Million | -350.37 Million |
| Dividends payments | - | - | -446.74 Million | - | -446.74 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -306 Thousand | 512 Thousand | 11.88 Million | -94 Thousand | 483.24 Million | 138.39 Million |
| Accounts receivables | -131.12 Million | -105.76 Million | 71.73 Million | 35.4 Million | -60.38 Million | 11.69 Million |
| Accounts payables | -18.32 Million | -3.28 Million | 40.63 Million | 81.74 Million | -63.3 Million | 14.18 Million |
| Inventory | -1.68 Million | -51.56 Million | -261.58 Million | -90.47 Million | 2.32 Million | -83.95 Million |
| Other working capital | 9.54 Million | -81.09 Million | 41.51 Million | 69.86 Million | 12.61 Million | 94.04 Million |
| Cash at beginning of period | 1.89 Billion | 2.03 Billion | 2.25 Billion | 1.95 Billion | 2.29 Billion | 2.29 Billion |
| Cash at end of period | 1.61 Billion | 1.89 Billion | 2.03 Billion | 2.03 Billion | 1.95 Billion | 2.29 Billion |
| Capital Expenditure | -92.56 Million | -185.94 Million | -633.83 Million | -140.56 Million | -164.47 Million | -128.57 Million |
| Effect of forex changes on cash | 1.17 Million | 1.12 Million | 2.47 Million | 7.29 Million | -9.04 Million | 5.8 Million |
| Net cash flow / Change in cash | -273.53 Million | -146.15 Million | -222.63 Million | 80.48 Million | -337.69 Million | -1.54 Million |
| Free Cash Flow | 74.11 Million | 59.99 Million | 751.82 Million | 285.73 Million | 200.28 Million | 171.02 Million |
LODZ
002315
TVGN
KE
NVMI
605196